# K241777: SmartAdjust™ Technology

- Pathway: 510(k) (Traditional)
- Applicant: Insulet Corporation
- Decided: Aug 26, 2024 after 67 days
- Product code: QJI (Interoperable Automated Glycemic Controller)
- Device class: 2
- Regulation: 21 CFR 862.1356
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K220394 (2022). 2 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K232741: SmartAdjust (TM) technology, Insulet Corporation (2024) Summary page 4.

## Most influential descendants
- K251779: Omnipod 5 algorithm (2025), 1 descendant of its own
- K261461: Omnipod 6 algorithm (2026), 0 descendants of its own

## Indications for use
SmartAdjust ™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. SmartAdjust ™ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. SmartAdjust ™ technology is intended for single patient use and requires a prescription.

Source page: https://510kreport.com/device/K241777
Methodology: https://510kreport.com/methodology